Terpos, E., Katodritou, E., Tsiftsakis, E., Kastritis, E., Christoulas, D., Pouli, A., . . . Zervas, K. (2009). Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration. Ferrata Storti Foundation.
Citação norma ChicagoTerpos, Evangelos, et al. Cystatin-C Is an Independent Prognostic Factor for Survival in Multiple Myeloma and Is Reduced By Bortezomib Administration. Ferrata Storti Foundation, 2009.
ציטוט MLATerpos, Evangelos, et al. Cystatin-C Is an Independent Prognostic Factor for Survival in Multiple Myeloma and Is Reduced By Bortezomib Administration. Ferrata Storti Foundation, 2009.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.